An appeals court ruling from late last week will revive a lawsuit over a Sanofi subsidiary's contamination issues and a ...
Bay­er stock­hold­ers will be get­ting a lot less re­ward for hold­ing their shares for the next few years. The Ger­man ...
Scientists from AI biotech Owkin and Google DeepMind have come together to form Bioptimus, a nascent French startup working ...
The drug industry officially has two new heavyweights. For the first time, Regeneron and Vertex have crossed the $100 billion ...
AstraZeneca’s Tagrisso has improved survival outcomes in a Phase III maintenance test for certain lung cancer patients, ...
Daiichi Sankyo is pouring €1 billion ($1.07 billion) into a German facility in part to expand its capacity for antibody-drug ...
Astel­las and BMS brands on the red car­pet. The Peo­ple’s Choice Awards may not be quite as high-pro­file as the Os­cars or ...
Takeda is leaning into a science-centric R&D campaign to help raise its profile in the US. The Japan-based pharma launched “Where Science Is” last year from its R&D communications group, but it ...
HelloFresh is now offering discounted meals to as many as 12 million Cigna insurance plan members through their employers. Working with a big health insurer is a new kind of relationship for ...
NodThera is moving its NLRP3 inhibitors into the clinic after preclinical data showed it reversed obesity and inflammation in mice in a study that compared it against Wegovy. In the trial, mice ...
Four ma­jor drug­mak­ers su­ing against the In­fla­tion Re­duc­tion Act are ask­ing to have their ar­gu­ments heard to­geth­er in court next month as part of a strat­e­gy le­gal ex­perts say could ...
Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will ...